<DOC>
	<DOCNO>NCT00876798</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability oral lixivaptan capsule subject Euvolemic Hyponatremia .</brief_summary>
	<brief_title>A Multicenter , Randomized , Double-blind , Placebo-controlled Study Evaluate Safety Tolerability Oral Lixivaptan Capsules Subjects With Euvolemic Hyponatremia</brief_title>
	<detailed_description>Phase I Phase II clinical trial demonstrate lixivaptan may play important role treat hyponatremia sign symptom water retention associate HF , LCWA , SIADH . Lixivaptan previously evaluate disease state characterize hyponatremia euvolemia ( SIADH ) hyponatremia combine fluid overload ( HF , LCWA ) . Lixivaptan demonstrate correction serum sodium concentration together mark aquaresis subject hyponatremia .</detailed_description>
	<mesh_term>Hyponatremia</mesh_term>
	<criteria>1 . Written informed consent . 2 . Men woman age 18 old . 3 . Diagnosis euvolemic hyponatremia ( Na+ &lt; 135 mEq/L ) . 4 . Willing observed monitor set approximately first 8 hour follow treatment initiation ( first dose ) . 5 . In Investigator 's judgement patient adequate visual auditory acuity allow participation trial . 1 . Pregnant breastfeed woman , woman plan become pregnant breastfeed . 2 . Overt symptoms hyponatremia require immediate medical intervention ( e.g. , coma , seizure ) . 3 . Acute transient hyponatremia ( e.g. , associate head trauma , postoperative state , use radiotherapy and/or chemotherapy ) . 4 . Hyponatremia hypovolemic state ( e.g. , due fluid loss vomiting , diarrhea , burn , etc. ) . Hypovolemic hyponatremia define presence clinical evidence extracellular fluid volume depletion . 5 . Hyponatremia hypervolemic state ( e.g. , congestive heart failure ) . Hypervolemia define presence increase total body water sign edema . 6 . Pseudohyponatremia ( i.e. , hyponatremia result laboratory artifact ) . 7 . Hypertonic hyponatremia ( e.g. , hyponatremia set hyperglycemia ) . 8 . Hyponatremia result medication safely withdrawn . 9 . Hyponatremia due hypothyroidism adrenal insufficiency . 10 . Current diagnosis psychogenic polydipsia . 11 . Receiving within 7 day enrollment medication treatment hyponatremia , specifically : demeclocycline , lithium carbonate , urea , vasopressin antagonist . 12 . Supine systolic arterial blood pressure â‰¤ 90 millimeter mercury ( mmHg ) . 13 . Serum creatinine &gt; 3.0 mg/dL ( &gt; 265.2 mol/L ) . 14 . Hypokalemia base clinical sign/symptoms lab finding ( e.g. , serum potassium &lt; 3.5 mEq/L ) . 15 . Uncontrolled diabetes mellitus define Investigators ( e.g. , hemoglobin glycosylated [ HbA1c ] &gt; 9 % ) . 16 . STsegment elevation myocardial infarction ( STEMI ) within 30 day active myocardial ischemia time enrollment . 17 . History cerebral vascular accident ( CVA ) within 30 day prior screen . 18 . Severe malnutrition Investigator 's judgment ( e.g. , body mass index [ BMI ] &lt; 17 ) . 19 . Advanced liver disease document diagnosis cirrhosis alcoholic hepatitis . 20 . Urinary tract obstruction ( benign prostatic hypertrophy [ BPH ] allow nonobstructive ) . 21 . History chronic drug/medication abuse within past 6 month current alcohol abuse . 22 . Terminally ill moribund condition little chance shortterm survival . 23 . Receiving vasopressin analog treatment condition . 24 . Known allergy vasopressin antagonist . 25 . Previous participation lixivaptan study . 26 . Recipient investigational treatment within 30 day prior baseline visit . 27 . Unable take oral medication . 28 . Significant neurological disorder ( e.g. , permanent neurological deficit , probable Alzheimer 's disease , normal pressure hydrocephalus , Parkinsonian dementia complex , multiinfarct dementia , mixed dementia , Huntington 's disease ) . 29 . Conditions limit access water inability respond thirst ( e.g. , hydrophobia , noncommunicative ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Euvolemic Hyponatremia</keyword>
	<keyword>SIADH</keyword>
	<keyword>Serum Sodium</keyword>
</DOC>